Open AccessGlucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage
Author(s) -
Ruxia Wang,
Hongchao Jiao,
Jingpeng Zhao,
Xiaojuan Wang,
Hai Lin
Publication year - 2016
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0156225
Subject(s) - myostatin , medicine , endocrinology , follistatin , skeletal muscle , muscle atrophy , phosphorylation , glucocorticoid , foxo1 , biology , protein degradation , pi3k/akt/mtor pathway , signal transduction , chemistry , protein kinase b , microbiology and biotechnology
Myostatin, a member of the TGF-β superfamily of secreted proteins, is expressed primarily in skeletal muscle. It negatively regulates muscle mass and is associated with glucocorticoid-induced muscle atrophy. However, it remains unclear whether myostatin is involved in glucocorticoid-induced muscle protein turnover. The aim of the present study was to investigate the role of myostatin in protein metabolism during dexamethasone (DEX) treatment. Protein synthesis rates and the expression of the genes for myostatin, ubiquitin-proteasome atrogin-1, MuRF1, FoxO1/3a and mTOR/p70S6K were determined. The results show that DEX decreased ( P <0.05) protein synthesis rates while increasing the abundance of myostatin. DEX increased ( P <0.05) the level of phospho-FoxO1/3a (Thr 24/32) and the expression of MuRF1. In contrast, DEX treatment had no detectable effect on atrogin-1 protein levels ( P >0.05). The phosphorylation levels of mTOR and p70S6K were decreased by DEX treatment ( P <0.05). Follistatin treatment inhibited the DEX-induced increase in myostatin ( P <0.05) and the activation of phosphor-FoxO1/3a (Thr 24/32) ( P < 0.05) and MuRF1 ( P <0.05). Follistatin treatment had no influence on the protein synthesis rate or on the phosphorylation levels of mTOR (Ser 2448) and p70S6K (Thr 389) ( P > 0.05). In conclusion, the present study suggests that the myostatin signalling pathway is associated with glucocorticoid-induced muscle protein catabolism at the beginning of exposure. Myostatin is not a main pathway associated with the suppression of muscle protein synthesis by glucocorticoids.